v3.25.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 2,189 $ 2,815
General and administrative 1,205 1,928
Total operating expenses 3,394 4,743
Loss from operations (3,394) (4,743)
Other income (expense):    
Interest income 15 140
Other income, net 32 0
Net loss $ (3,347) $ (4,603)
Loss per share, basic (in dollars per share) $ (0.22) $ (0.34)
Loss per share, diluted (in dollars per share) $ (0.22) $ (0.34)
Weighted average number of shares of common stock, basic (in shares) 15,173,196 13,709,487
Weighted average number of shares of common stock, diluted (in shares) 15,173,196 13,709,487

Source